Occlusion and catheter ablation using a large-size cryoballoon for various pulmonary veins: a case series

• Published in: European Heart Journal - Case Reports Vol. 7; no. 12; p. ytad593
• Main Authors: Yoshizawa, Reisuke, Sasaki, Hiroki, Urushikubo, Takashi, Sawa, Yohei, Owada, Shingen
• Format: Journal Article
• Language: English
• Published: US Oxford University Press (OUP) 01.12.2023; Oxford University Press
• Subjects: Ablation; Cardiac arrhythmia; Case Series; Occlusion; Case report; Cryoballoon; Catheter ablation; Atrial fibrillation; Pulmonary vein isolation
• ISSN: 2514-2119; 2514-2119
• DOI: 10.1093/ehjcr/ytad593

Abstract Background It is established that pulmonary vein isolation using the POLARx™ (Boston Scientific, Marlborough, MA, USA) cryoballoon is a rapid, safe, and effective approach. The new POLARx™ FIT (Boston Scientific), which is expandable from 28 to 31 mm in diameter, is currently available. However, there is limited evidence available regarding the treatment of atrial fibrillation in this setting. In this article, we report a case series of cryoballoon ablation in patients with atrial fibrillation using POLARx™ FIT. Case summary This case series describes a comparison of obstruction in three patients with pulmonary veins of different shapes and diameters undergoing cryoballoon ablation and pulmonary vein isolation with a 31 mm diameter balloon. Discussion Cryoballoon ablation using the 31 mm mode of POLARx™ FIT has the potential to provide safe and stable pulmonary vein isolation with good occlusion for a variety of pulmonary vein geometries. In this case series, the 31 mm mode of the POLARx™ FIT resulted in better pulmonary vein occlusion than the 28 mm mode in patients with large left atria and large pulmonary veins, including the left common pulmonary vein. This approach may be considered a first-line therapy option of cryoballoon ablation in patients with atrial fibrillation.